Study Stopped
Study terminated due to resource constraints and inadequate funding.
Understanding Coagulation and Inflammation in Burns
1 other identifier
observational
120
1 country
1
Brief Summary
The purpose of this study is to understand what happens to platelets and blood clotting factors in burn patients over time. This study will also examine the role of microparticles (MPs), nanoparticles (NPs), and micro RNA in burns. The investigators will be looking at small particles of cells that are released into the blood. These particles have been found to be important in a variety of different diseases. The investigators believe that MPs, NPs, and micro RNA may play a role in development of inflammation, and infections in burn patients. Thus, hopefully, this study will help understand how to minimize transfusions and bleeding in burn patients as well as how to reduce inflammation and infections in burn patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2025
CompletedFebruary 13, 2026
January 1, 2026
9.1 years
March 1, 2017
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
measurement of coagulation factor levels over time
coagulation factor levels will be measured using laboratory testing
during hospital admission for up to 30 days
development of sepsis and infections
sepsis and infection will be monitored using CRP values by lab testing as well as blood and urine cultures
during hospital admission for up to 30 days
Eligibility Criteria
all patients presenting with 2nd or 3rd degree burns older than age 18
You may qualify if:
- Adults \>18 years of age with 2nd and/or 3rd degree burns and any degree of associated trauma
- Elderly
You may not qualify if:
- Children \<18 years of age
- Prisoners
- Pregnant females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
Biospecimen
plasma and microparticles
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 1, 2017
First Posted
March 10, 2017
Study Start
May 1, 2016
Primary Completion
May 19, 2025
Study Completion
May 19, 2025
Last Updated
February 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share